ScoreWhy is Prime Medicine, Inc. ?
1
With a growth in Operating Profit of 10.15%, the company declared Very Positive results in Sep 25
- The company has declared positive results for the last 2 consecutive quarters
- NET SALES(HY) At USD 2.34 MM has Grown at 1,019.62%
- OPERATING CASH FLOW(Y) Highest at USD -109.07 MM
- NET PROFIT(HY) Higher at USD -104.12 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 94.71%, its profits have risen by 2.1%
3
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -0.91% over the previous quarter and currently hold 12.65% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
4
Market Beating Performance
- The stock has generated a return of 94.71% in the last 1 year, much higher than market (S&P 500) returns of 20.78%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Prime Medicine, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Prime Medicine, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Prime Medicine, Inc.
94.71%
-0.42
111.80%
S&P 500
20.78%
1.08
19.33%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
62.54%
EBIT Growth (5y)
-253.52%
EBIT to Interest (avg)
-162.81
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.29
Sales to Capital Employed (avg)
0.02
Tax Ratio
0.07%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
43.46%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
18.09
EV to EBIT
-4.93
EV to EBITDA
-5.10
EV to Capital Employed
-29.93
EV to Sales
202.93
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-325.32%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
NET SALES(HY)
At USD 2.34 MM has Grown at 1,019.62%
OPERATING CASH FLOW(Y)
Highest at USD -109.07 MM
NET PROFIT(HY)
Higher at USD -104.12 MM
RAW MATERIAL COST(Y)
Fallen by -91.56% (YoY
EPS(Q)
Highest at USD -0.32
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Prime Medicine, Inc.
Net Sales
At USD 2.34 MM has Grown at 1,019.62%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Profit
Higher at USD -104.12 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -109.07 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
EPS
Highest at USD -0.32
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -91.56% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 1.88 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
